title: Corticotropin-releasing factor-overexpressing mice exhibit reduced neuronal activation in the arcuate nucleus and food intake in response to fasting.
abstract: Corticotropin-releasing factor (CRF) overexpressing (OE) mice are a genetic model that exhibits features of chronic stress. We investigated whether the adaptive feeding response to a hypocaloric challenge induced by food deprivation is impaired under conditions of chronic CRF overproduction. Food intake response to a 16-h overnight fast and ip injection of gut hormones regulating food intake were compared in CRF-OE and wild type (WT) littermate mice along with brain Fos expression, circulating ghrelin levels, and gastric emptying of a nonnutrient meal. CRF-OE mice injected ip with saline showed a 47 and 44% reduction of 30-min and 4-h cumulative food intake response to an overnight fast, respectively, compared with WT. However, the 30-min food intake decrease induced by ip cholecystokinin (3 microg/kg) and increase by ghrelin (300 microg/kg) were similar in CRF-OE and WT mice. Overnight fasting increased the plasma total ghrelin to similar levels in CRF-OE and WT mice, although CRF-OE mice had a 2-fold reduction of nonfasting ghrelin levels. The number of Fos-immunoreactive cells induced by fasting in the arcuate nucleus was reduced by 5.9-fold in CRF-OE compared with WT mice whereas no significant changes were observed in other hypothalamic nuclei. In contrast, fasted CRF-OE mice displayed a 5.6-fold increase in Fos-immunoreactive cell number in the dorsal motor nucleus of the vagus nerve and a 34% increase in 20-min gastric emptying. These findings indicate that sustained overproduction of hypothalamic CRF in mice interferes with fasting-induced activation of arcuate nucleus neurons and the related hyperphagic response.
authors.affiliation: Center for Ulcer Research and Education, Digestive Diseases Research Center, Digestive Diseases Division, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90073, USA.
authors.forename: Andreas
authors.initials: A
authors.lastname: Stengel
authors.forename: Miriam
authors.initials: M
authors.lastname: Goebel
authors.forename: Mulugeta
authors.initials: M
authors.lastname: Million
authors.forename: Mary P
authors.initials: MP
authors.lastname: Stenzel-Poore
authors.forename: Peter
authors.initials: P
authors.lastname: Kobelt
authors.forename: Hubert
authors.initials: H
authors.lastname: Mönnikes
authors.forename: Yvette
authors.initials: Y
authors.lastname: Taché
authors.forename: Lixin
authors.initials: L
authors.lastname: Wang
mesh_terms: D000818:Animals; D001111:Arcuate Nucleus of Hypothalamus / Q000187:drug effects / Q000502:physiology*; D002766:Cholecystokinin / Q000494:pharmacology; D003346:Corticotropin-Releasing Hormone / Q000235:genetics*; D004435:Eating / Q000187:drug effects / Q000502:physiology*; D002149:Energy Intake / Q000187:drug effects; D005215:Fasting / Q000502:physiology*; D005746:Gastric Emptying / Q000187:drug effects / Q000502:physiology; D005786:Gene Expression Regulation; D016762:Genes, fos; D054439:Ghrelin / Q000494:pharmacology; D006963:Hyperphagia / Q000503:physiopathology; D007033:Hypothalamus, Middle / Q000187:drug effects / Q000502:physiology; D051379:Mice; D009474:Neurons / Q000502:physiology*; D018697:Nootropic Agents / Q000494:pharmacology; D012844:Sincalide / Q000031:analogs & derivatives / Q000494:pharmacology
chemical_list: C090019:8-sulfocholecystokinin octapeptide; D054439:Ghrelin; D018697:Nootropic Agents; D002766:Cholecystokinin; D003346:Corticotropin-Releasing Hormone; D012844:Sincalide
references.citation: Endocrinology. 2007 Feb;148(2):638-46
references.pmid: 17068131
references.citation: J Neuroendocrinol. 1996 Oct;8(10):733-5
references.pmid: 8910801
references.citation: Life Sci. 2008 Apr 9;82(15-16):862-8
references.pmid: 18343456
references.citation: Endocrinology. 2004 Feb;145(2):930-40
references.pmid: 14576181
references.citation: J Neuroendocrinol. 2001 Dec;13(12):1066-75
references.pmid: 11722703
references.citation: Am J Physiol Regul Integr Comp Physiol. 2007 Apr;292(4):R1429-38
references.pmid: 17194724
references.citation: Nutr Metab Cardiovasc Dis. 2004 Aug;14(4):173-9
references.pmid: 15553593
references.citation: Nutr Metab Cardiovasc Dis. 2008 Feb;18(2):158-68
references.pmid: 18061414
references.citation: Eur J Pharmacol. 2002 Apr 12;440(2-3):189-97
references.pmid: 12007535
references.citation: Brain Res. 1993 Jul 30;618(1):76-82
references.pmid: 8402180
references.citation: Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10455-60
references.pmid: 9294232
references.citation: Neurosci Lett. 2003 May 1;341(2):151-5
references.pmid: 12686388
references.citation: Endocrinology. 2006 Jan;147(1):520-9
references.pmid: 16210367
references.citation: Gastroenterology. 2001 Feb;120(2):337-45
references.pmid: 11159873
references.citation: Peptides. 2001 May;22(5):733-41
references.pmid: 11337086
references.citation: Diabetes. 2002 Dec;51(12):3412-9
references.pmid: 12453894
references.citation: Nature. 1999 Dec 9;402(6762):656-60
references.pmid: 10604470
references.citation: Endocrinology. 1999 Oct;140(10):4551-7
references.pmid: 10499510
references.citation: J Neuroendocrinol. 2008 Jan;20(1):85-92
references.pmid: 18081556
references.citation: Mol Cell Biol. 2003 Nov;23(22):7973-81
references.pmid: 14585959
references.citation: J Neurosci. 1994 May;14(5 Pt 1):2579-84
references.pmid: 8182429
references.citation: Psychoneuroendocrinology. 1997 May;22(4):215-24
references.pmid: 9226726
references.citation: Am J Physiol. 1988 Jul;255(1 Pt 2):R141-8
references.pmid: 3293471
references.citation: Eur J Neurosci. 2002 Nov;16(9):1751-60
references.pmid: 12431228
references.citation: Auton Neurosci. 2006 Apr 30;125(1-2):42-52
references.pmid: 16520096
references.citation: Eur J Endocrinol. 2004 Jul;151(1):113-7
references.pmid: 15248830
references.citation: Front Neuroendocrinol. 1993 Oct;14(4):303-47
references.pmid: 8258378
references.citation: Int J Obes Relat Metab Disord. 2004 Dec;28 Suppl 4:S45-52
references.pmid: 15592486
references.citation: Neuroreport. 2008 Jan 8;19(1):105-9
references.pmid: 18281902
references.citation: Am J Physiol. 1995 Nov;269(5 Pt 2):R949-57
references.pmid: 7503322
references.citation: J Clin Invest. 2007 Jan;117(1):33-40
references.pmid: 17200704
references.citation: Gastroenterology. 2003 Sep;125(3):654-9
references.pmid: 12949710
references.citation: Trends Endocrinol Metab. 1993 Mar;4(2):62-9
references.pmid: 18407136
references.citation: Brain Res. 1994 Jul 25;652(1):56-64
references.pmid: 7953723
references.citation: Am J Physiol. 1991 Jan;260(1 Pt 2):R200-7
references.pmid: 1992820
references.citation: Annu Rev Pharmacol Toxicol. 2004;44:525-57
references.pmid: 14744257
references.citation: J Pharmacol Exp Ther. 2004 Nov;311(2):427-40
references.pmid: 15297468
references.citation: Endocrinology. 1992 Jun;130(6):3378-86
references.pmid: 1597149
references.citation: Nature. 2000 Apr 6;404(6778):661-71
references.pmid: 10766253
references.citation: Biol Psychiatry. 2002 Jun 1;51(11):875-81
references.pmid: 12022960
references.citation: Endocrinology. 1998 May;139(5):2629-35
references.pmid: 9564880
references.citation: J Neuroendocrinol. 2004 Feb;16(2):105-12
references.pmid: 14763996
references.citation: J Comp Neurol. 1980 Dec 1;194(3):555-70
references.pmid: 7451682
references.citation: Physiol Behav. 2008 May 23;94(2):169-77
references.pmid: 18275977
references.citation: Am J Physiol Regul Integr Comp Physiol. 2007 Jan;292(1):R291-307
references.pmid: 16990483
references.citation: Am J Physiol. 1997 Jul;273(1 Pt 2):R113-20
references.pmid: 9249540
references.citation: J Neuroendocrinol. 2000 Nov;12(11):1047-9
references.pmid: 11069119
references.citation: Ann N Y Acad Sci. 1994 Mar 23;713:236-41
references.pmid: 8185165
references.citation: Trends Pharmacol Sci. 2003 Aug;24(8):421-7
references.pmid: 12915052
references.citation: Endocrinology. 1999 Sep;140(9):4015-23
references.pmid: 10465271
references.citation: Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4679-84
references.pmid: 15070777
references.citation: J Clin Endocrinol Metab. 2001 Oct;86(10):4753-8
references.pmid: 11600536
references.citation: Brain Res. 1998 Apr 27;791(1-2):157-66
references.pmid: 9593872
references.citation: Nutr Neurosci. 2004 Oct-Dec;7(5-6):271-80
references.pmid: 15682923
references.citation: Am J Physiol Regul Integr Comp Physiol. 2008 Aug;295(2):R404-16
references.pmid: 18550868
references.citation: Eur J Neurosci. 2002 Jun;15(12):2007-15
references.pmid: 12099906
references.citation: Neurosci Lett. 2002 May 31;325(1):47-51
references.pmid: 12023064
references.citation: Brain Res. 1993 May 14;611(1):18-24
references.pmid: 8518948
references.citation: Peptides. 2001 Jan;22(1):81-90
references.pmid: 11179601